Stem Cells News and Research

RSS

Stem cells have the remarkable potential to develop into many different cell types in the body during early life and growth. In addition, in many tissues they serve as a sort of internal repair system, dividing essentially without limit to replenish other cells as long as the person or animal is still alive. When a stem cell divides, each new cell has the potential either to remain a stem cell or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell.

NeoStem responds to court ruling blocking government funding for embryonic stem cell research

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, commented today on the ruling this week of a U.S. District Court blocking the federal government from funding research involving human embryonic stem cells. In issuing a preliminary injunction, the judge said it violated a law first passed in 1996 prohibiting federal money for research where a human embryo is destroyed.

25 Aug 2010

NIH awards University of Rochester Medical Center $15M grant for study with ImmuneRegen's Homspera

ImmuneRegen BioSciences®, a wholly owned subsidiary of IR Biosciences Holdings Inc., today announced that the National Institute of Health/National Institute of Allergy and Infectious Disease, has awarded its research partner, the University of Rochester Medical Center (URMC), a $15 million five-year, continuation grant for studies that will utilize ImmuneRegen's Homspera.

25 Aug 2010

Stem cell therapy cures 12-year-old boy with diabetes

Cellonis Biotechnologies, a Beijing and HK-based medical research and application company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing partner hospital. He has completely regained his normal life, enjoying sports and school activities just like every other person his age, and has been free from injections and drugs for more than half a year.

25 Aug 2010

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

Human umbilical cord blood cells (HUCB) used to treat cultured rat brain cells (astrocytes) deprived of oxygen appear to protect astrocytes from cell death after stroke-like damage, reports a team of researchers from the University of South Florida (USF) Department of Neurosurgery and Brain Repair.

25 Aug 2010

First Edition: August 25, 2010

In today's headlines, news about a Medicare change that may cause an estimated three million seniors to switch their drug coverage.

25 Aug 2010

BIO president comments on U.S. District Court injunction on embryonic stem cell research funds

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research.

25 Aug 2010

Judge blocks federal funding of human embryonic stem cell research

The Washington Post: "A federal judge on Monday blocked the Obama administration from funding human embryonic stem cell research, ruling that the support violates a federal law barring the use of taxpayer money for experiments that destroy human embryos.

25 Aug 2010

Researchers identify novel approach to decrease glioblastoma multiforme recurrence

Researchers from the University of Massachusetts Medical School have identified a novel approach of combining chemotherapy with a targeted therapy to decrease the recurrence of glioblastoma multiforme, the most common and aggressive brain tumor.

25 Aug 2010

Also in Global Health News: IDUs in Kenya; Haiti recovery; Pandemic preparedness; Somalia hunger; HIV in Mozambique; Strengthening immune system against HIV

In Kenya, "[i]ntravenous drug users (IDUs) have been largely ignored by the government's HIV programmes on the basis that drug-taking is illegal, but a new policy is being drafted with the aim of reducing HIV transmission among this high-risk group," IRIN/PlusNews reports. The article includes comments from Nicholas Muraguri, head of the National AIDS and Sexually Transmitted Infections Control Programme, who said that the policy would treat drug use as a health issue, not a criminal one.

25 Aug 2010

Stem cell research issues fought out in the court

A US district court has issued a temporary injunction stopping President Obama’s plans to increase funding for human embryonic stem cell research. The US government will appeal. According to a Justice Department spokesman, they are likely to file a case this week.

24 Aug 2010

First Edition: August 24, 2010

In today's headlines, a federal court judge blocks the Obama administration's stem cell policy. Meanwhile, state action related to health reform and health policy continues.

24 Aug 2010

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Family Research Council President Tony Perkins applauded today's preliminary injunction that for now stops taxpayer funded embryonic stem cell research. Judge Royce Lamberth noted that the imposition of an injunction required that those challenging the government's funding demonstrate a substantial likelihood of success on the merits for their arguments.

24 Aug 2010

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

A desire to understand how breast cancer starts has seen Walter and Eliza Hall Institute researcher Dr Marie-Liesse Asselin-Labat today win one of three 2010 L'Oreal Australia For Women in Science Fellowships.

24 Aug 2010

Study enhances use of stem cells for organ regeneration

Cindy Morrissey, President and CEO of Emerging Healthcare Solutions, Inc., called the results of a recent study on Friday an 'encouraging step' towards the use of stem cells to regenerate human organs.

24 Aug 2010

FDA OOPD awards Soligenix $1.2M for orBec Phase 3 study in acute gastrointestinal Graft-versus-Host-Disease

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that it has been awarded a three year $1.2 million clinical research grant by the Office of Orphan Products Development (OOPD) of the U.S. Food and Drug Administration (FDA) pursuant to its Orphan Products Development (OPD) Program.

24 Aug 2010

SEB opens new state-of-the-art laboratory operation, R&D facility

Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.

23 Aug 2010

Scientists develop new synthetic material to grow stem cells

Human pluripotent stem cells, which can become any other kind of body cell, hold great potential to treat a wide range of ailments, including Parkinson's disease, multiple sclerosis and spinal cord injuries. However, scientists who work with such cells have had trouble growing large enough quantities to perform experiments - in particular, to be used in human studies. Furthermore, most materials now used to grow human stem cells include cells or proteins that come from mice embryos, which help stimulate stem-cell growth but would likely cause an immune reaction if injected into a human patient.

23 Aug 2010

New diagnostic tool proves cost-effective in identifying rare genetic disorders

Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders. With support from the National Institutes of Health, researchers found those mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.

23 Aug 2010

Cell-depleted lung used as natural growth matrix for generating new rat lung from embryonic stem cells

The first successful report of using cell-depleted lung as a natural growth matrix for generating new rat lung from embryonic stem cells is presented in a breakthrough article in Tissue Engineering, Part A, a peer-reviewed journal published by Mary Ann Liebert, Inc..

20 Aug 2010

Human neural stem cells restore motor function in mice with chronic spinal cord injury

StemCells, Inc. announced today the publication of new preclinical data demonstrating that the Company's proprietary human neural stem cells restore lost motor function in mice with chronic spinal cord injury. This is the first published study to show that human neural stem cells can restore mobility even when administered at time points beyond the acute phase of trauma, suggesting the prospect of treating a much broader population of injured patients than previously demonstrated.

20 Aug 2010

Stem Cells News and Research

Further Reading

NeoStem responds to court ruling blocking government funding for embryonic stem cell research

NIH awards University of Rochester Medical Center $15M grant for study with ImmuneRegen's Homspera

Stem cell therapy cures 12-year-old boy with diabetes

Human umbilical cord blood cells appear to protect astrocytes from cell death: Research

First Edition: August 25, 2010

BIO president comments on U.S. District Court injunction on embryonic stem cell research funds

Judge blocks federal funding of human embryonic stem cell research

Researchers identify novel approach to decrease glioblastoma multiforme recurrence

Also in Global Health News: IDUs in Kenya; Haiti recovery; Pandemic preparedness; Somalia hunger; HIV in Mozambique; Strengthening immune system against HIV

Stem cell research issues fought out in the court

First Edition: August 24, 2010

FRC applauds preliminary injunction to stop taxpayers for embryonic stem cell research

Walter and Eliza Hall Institute researcher receives L'Oreal Fellowship for breast cancer research

Study enhances use of stem cells for organ regeneration

FDA OOPD awards Soligenix $1.2M for orBec Phase 3 study in acute gastrointestinal Graft-versus-Host-Disease

SEB opens new state-of-the-art laboratory operation, R&D facility

Scientists develop new synthetic material to grow stem cells

New diagnostic tool proves cost-effective in identifying rare genetic disorders

Cell-depleted lung used as natural growth matrix for generating new rat lung from embryonic stem cells

Human neural stem cells restore motor function in mice with chronic spinal cord injury

Stem Cells eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo